Onconomics Extracts Plus is an advanced panel which offers invaluable insights into identifying optimal natural treatments for cancer. With a focus on over 50 natural extracts and substances, Onconomics Extracts Plus provides detailed information on their efficacy as anticancer agents. By creating individualized profiles based on gene expressions of cancer cells, Onconomics Extracts Plus sheds light on cancer behavior within the body.
This comprehensive test provides data to design a treatment plan that addresses the underlying biological processes driving your cancer, such as angiogenesis (blood vessel formation) or cell proliferation.
The test measures the CTC count in the blood. The increase or decrease in count will help clinicians and patients understand the progression of cancer and treatment response.
The gene expression reveals details about how quickly the body lays down blood supply to feed cancer cells, how quickly the cancer cells become resistant to treatment, and how sensitive they are.
The gene expression profile analyzes genes associated with fundamental biological processes. The processes include Angiogenesis, Self-repair, Metastasis, Apoptosis, and Proliferation.
By analyzing these processes at the genetic level, we gain a comprehensive understanding of cancer behavior, empowering personalized treatment approaches tailored to each patient’s unique profile.
Natural substances have been used around the world to treat cancer. To know which natural substance can be used for each patient’s unique cancer, Onconomics Extracts is suggested. With our comprehensive analysis, we identify which natural substances hold promise for your unique cancer profile. We also provide personalized recommendations tailored to individual needs based on the analysis.
The test explores a range of natural substances alongside conventional therapies, providing a comprehensive overview of potential treatment options.
Oncotrail has undergone rigorous evaluation to ensure high sensitivity and specificity, making it an invaluable tool for diagnostic purposes.
Through high-precision techniques, the test is used to monitor the effectiveness of a particular cancer treatment. This would objectively provide information on how well the treatment is going.
The non-invasive tracking of the cancer status would notify a treating physician whether to adjust current management or stay the course. This would be important to know in almost real-time rather than to find out much later that a treatment doesn't apply to a particular person.
Whole peripheral blood sample, Tissue for CNS primary tumors
15-25 ml blood, minimum 400 mg tissue
10-12 days in the lab
21 days after sample collection
Applicable for all cancer types
To whom it is relevant: The test is suitable for patients seeking alternative approaches to traditional chemotherapy or exploring options after exhausting conventional treatments
A patient-centric revolution in cancer testing and monitoring. We are devoted to providing personalized tests designed with each patient’s unique genetic profile in mind.
©2024 All Rights Reserved. Designed by Bee High Media.
